Sensitivity and Specificity of Pathologic Findings to Diagnose Lupus Nephritis
- 25 October 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (11) , 1605-1615
Abstract
Background and objectives: In 2012, the Systemic Lupus International Collaborating Clinics proposed that lupus nephritis, in the presence of positive ANA or anti-dsDNA antibody, is sufficient to diagnose SLE. However, this “stand-alone” kidney biopsy criterion is problematic because the ISN/RPS classification does not specifically define lupus nephritis. We investigated the combination of pathologic features with optimal sensitivity and specificity for the diagnosis of lupus nephritis. Design, setting, participants, & measurements: Three hundred consecutive biopsies with lupus nephritis and 560 contemporaneous biopsies with nonlupus glomerulopathies were compared. Lupus nephritis was diagnosed if there was a clinical diagnosis of SLE and kidney biopsy revealed findings compatible with lupus nephritis. The control group consisted of consecutives biopsies showing diverse glomerulopathies from patients without SLE, including IgA nephropathy, membranous glomerulopathy, pauci-immune glomerulonephritis, membranoproliferative glomerulonephritis (excluding C3 GN), and infection-related glomerulonephritis. Sensitivity and specificity of individual pathologic features and combinations of features were computed. Results: Five characteristic features of lupus nephritis were identified: “full-house” staining by immunofluorescence, intense C1q staining, extraglomerular deposits, combined subendothelial and subepithelial deposits, and endothelial tubuloreticular inclusions, each with sensitivity ranging from 0.68 to 0.80 and specificity from 0.8 to 0.96. The presence of at least two, three, or four of the five criteria had a sensitivity of 0.92, 0.8, and 0.66 for the diagnosis of lupus nephritis, and a specificity of 0.89, 0.95, and 0.98. Conclusions: In conclusion, combinations of pathologic features can distinguish lupus nephritis from nonlupus glomerulopathies with high specificity and varying sensitivity. Even with stringent criteria, however, rare examples of nonlupus glomerulopathies may exhibit characteristic features of lupus nephritis.Keywords
Funding Information
- National Institute on Minority Health and Health Disparities (R01MD009223)
This publication has 20 references indexed in Scilit:
- Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indicesKidney International, 2018
- Validation of the Systemic Lupus International Collaborating Clinics classification criteria in a cohort of patients with full house glomerular depositsKidney International, 2018
- Idiopathic non-lupus full-house nephropathy is associated with poor renal outcomeNephrology Dialysis Transplantation, 2017
- Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral TherapyKidney International Reports, 2016
- Immune Complex Disease With a Lupus-like Pattern of Deposition in an Antinuclear Antibody–Negative PatientAmerican Journal of Kidney Diseases, 2013
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- Renal-limited 'lupus-like' nephritisNephrology Dialysis Transplantation, 2011
- Clinicopathological study of originally non-lupus “full-house” nephropathyRenal Failure, 2010
- The Classification of Glomerulonephritis in Systemic Lupus Erythematosus RevisitedJournal of the American Society of Nephrology, 2004
- Pathologic differentiation between lupus and nonlupus membranous glomerulopathyKidney International, 1983